DK3256483T3 - Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav - Google Patents

Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav Download PDF

Info

Publication number
DK3256483T3
DK3256483T3 DK16784277.2T DK16784277T DK3256483T3 DK 3256483 T3 DK3256483 T3 DK 3256483T3 DK 16784277 T DK16784277 T DK 16784277T DK 3256483 T3 DK3256483 T3 DK 3256483T3
Authority
DK
Denmark
Prior art keywords
triterpenon
unknown
reverse
amide derivatives
hiv inhibitors
Prior art date
Application number
DK16784277.2T
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Krupadanam Gazula Levi David
Reddy Adulla Panduranga
Reddy Kasireddy Bhaskar
Subrahmanyam Lanka Vl
Reddy Kura Rathnakar
Original Assignee
Hetero Labs Ltd
Dfh Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57153504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3256483(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hetero Labs Ltd, Dfh Therapeutics Inc filed Critical Hetero Labs Ltd
Application granted granted Critical
Publication of DK3256483T3 publication Critical patent/DK3256483T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16784277.2T 2015-02-09 2016-02-09 Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav DK3256483T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN623CH2015 2015-02-09
PCT/IB2016/000811 WO2016178092A2 (en) 2015-02-09 2016-02-09 C-3 novel triterpenone with c-28 reverse amide derivatives as hiv inhibitors

Publications (1)

Publication Number Publication Date
DK3256483T3 true DK3256483T3 (da) 2020-03-23

Family

ID=57153504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16784277.2T DK3256483T3 (da) 2015-02-09 2016-02-09 Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav

Country Status (22)

Country Link
US (3) US10533035B2 (da)
EP (1) EP3256483B1 (da)
JP (1) JP2018505216A (da)
KR (1) KR20170110143A (da)
CN (1) CN107428797A (da)
AU (1) AU2016258274B2 (da)
BR (1) BR112017017109A2 (da)
CA (1) CA2975359A1 (da)
CL (1) CL2017002034A1 (da)
CO (1) CO2017008765A2 (da)
CU (1) CU24476B1 (da)
DK (1) DK3256483T3 (da)
EA (1) EA033264B1 (da)
ES (1) ES2780649T3 (da)
IL (1) IL253844A0 (da)
MA (1) MA40886B1 (da)
MX (1) MX2017010297A (da)
PE (1) PE20171433A1 (da)
PH (1) PH12017550077A1 (da)
SG (1) SG11201706189PA (da)
WO (1) WO2016178092A2 (da)
ZA (1) ZA201705253B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
US10370405B2 (en) 2015-03-16 2019-08-06 Hetero Labs Limited C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
AR107512A1 (es) 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
WO2018029604A1 (en) * 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors
WO2019150300A1 (en) 2018-02-02 2019-08-08 Glaxosmithkline Intellectual Property (No.2) Limited Crystalline forms of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid
GEP20237476B (en) 2018-09-21 2023-03-27 Pfizer N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors
CN109705189B (zh) * 2018-12-29 2020-06-05 中国医学科学院药用植物研究所 具有式i所示结构的三萜衍生物及其制备方法和应用
US12378281B2 (en) * 2019-02-11 2025-08-05 Hetero Labs Limited Triterpenone derivatives as HIV inhibitors

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152815A (ja) 1982-03-05 1983-09-10 Tamio Nishimura 医療用抗ウイルス剤
AU699168B2 (en) 1993-07-09 1998-11-26 University Of Pittsburgh Selection and use of antiviral peptides
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
WO1998046238A1 (en) 1997-04-15 1998-10-22 Medichem Research, Inc. Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
HUP9701080A3 (en) 1997-06-23 1999-05-28 Gene Res Lab Inc New York N Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
US6670345B1 (en) 1997-09-30 2003-12-30 Dabur Research Foundation Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
US6427248B1 (en) 1997-10-09 2002-08-06 David M. Albert Grip-enhancing glove
KR20010080507A (ko) 1998-11-18 2001-08-22 추후보정 신규한 베툴린산 유도체, 그의 제조 방법 및 암 성장억제제로서의 그의 용도
AU7268000A (en) 1999-07-21 2001-02-13 Martin Heinkelein Method for quantization of the antiviral effect of antiviral active principles
JP2003508543A (ja) 1999-09-09 2003-03-04 ダブール リサーチ ファンデーション 抗脈管形成活性を有する新規なベツリン酸誘導体、該誘導体を調整する方法、および腫瘍に関連する脈管形成を処置するためのそれらの使用
WO2002091858A1 (en) 2001-05-11 2002-11-21 University Of Ottawa Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
WO2003037908A1 (en) 2001-10-31 2003-05-08 Ribapharm Inc. Antiviral combination therapy and compositions
EP1594885B8 (de) 2003-02-11 2009-03-25 Novelix Pharmaceuticals, Inc. Medikament zur wachstumsinhibierung von tumoren
US7026305B2 (en) 2003-04-14 2006-04-11 Meharry Medical College Anti-HIV agents with dual sites of action
MXPA06010592A (es) 2004-03-17 2007-06-12 Panacos Pharmaceuticals Inc Sales farmaceuticas de acido 3-o-(3',3'-dimetilsuccinil) betulinico.
KR101021828B1 (ko) 2004-10-27 2011-03-17 다이이찌 산쿄 가부시키가이샤 2 이상의 치환기를 갖는 벤젠 화합물
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
WO2006105356A2 (en) 2005-03-29 2006-10-05 Regents Of The University Of Minnesota Methods of manufacturing bioactive 3-esters of betulinic aldehyde and betulinic acid
WO2007002411A1 (en) 2005-06-22 2007-01-04 Myriad Genetics, Inc. Antiviral compounds
CN101287744A (zh) 2005-06-22 2008-10-15 美瑞德生物工程公司 抗病毒化合物
CN100475835C (zh) 2006-05-12 2009-04-08 中国药科大学 23-羟基白桦酸类衍生物、其制备方法、制剂及用途
FI20065389L (fi) 2006-06-07 2007-12-31 Valtion Teknillinen Betuliiniperäiset yhdisteet kasvien tuholaisten syönnin estäjinä
FI121468B (fi) 2006-06-07 2010-11-30 Valtion Teknillinen Betuliiniperäiset yhdisteet antimikrobisina aineina
WO2008127364A2 (en) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
US20110144069A1 (en) 2006-10-16 2011-06-16 Myriad Genetics, Incorporated Compounds for treating viral infections
TW200837074A (en) * 2006-11-03 2008-09-16 Panacos Pharmaceuticals Inc Extended triterpene derivatives
US20110152229A1 (en) 2006-11-22 2011-06-23 Duke University Betulinic acid derivatives as anti-hiv agents
WO2008091532A1 (en) 2007-01-19 2008-07-31 Panacos Pharmaceuticals, Inc. Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof
EP2240504A1 (en) 2008-01-03 2010-10-20 Virochem Pharma Inc. Novel c-21-keto lupane derivatives preparation and use thereof
EP2250185A4 (en) * 2008-01-03 2011-11-16 Virochem Pharma Inc NEW LUPANDERIVATE
AU2009214779A1 (en) 2008-02-14 2009-08-20 Virochem Pharma Inc. Novel 17beta lupane derivatives
US8431556B2 (en) 2008-03-26 2013-04-30 Vertex Pharmaceuticals Incorporated C-21-keto lupane derivatives preparation and use thereof
WO2010132334A1 (en) 2009-05-15 2010-11-18 The University Of North Carolina At Chapel Hill 3,28-disubstituted betulinic acid derivatives as anti-hiv agents
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
US8802727B2 (en) 2009-07-14 2014-08-12 Hetero Research Foundation, Hetero Drugs Limited Pharmaceutically acceptable salts of betulinic acid derivatives
JP2013519674A (ja) 2010-02-11 2013-05-30 グラクソスミスクライン エルエルシー ベツリンの誘導体
BR112012030818A2 (pt) 2010-06-04 2019-09-24 Bristol-Myers Squibb Company "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv"
WO2011153319A1 (en) 2010-06-04 2011-12-08 Bristol-Myers Squibb Company C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors
WO2012095705A1 (en) 2011-01-10 2012-07-19 Hetero Research Foundation Pharmaceutically acceptable salts of novel betulinic acid derivatives
CN103620621B (zh) 2011-06-30 2017-10-24 诺基亚技术有限公司 用于利用积分梯度投影的面部跟踪的方法和装置
WO2013020245A1 (en) 2011-08-08 2013-02-14 Glaxosmithkline Llc Carbonyl derivatives of betulin
EP2791102B1 (en) 2011-12-14 2016-05-18 Glaxosmithkline LLC Propenoate derivatives of betulin
WO2013091144A1 (en) 2011-12-21 2013-06-27 Glaxosmithkline Llc Propenoate derivatives of betulin
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
CN103242413B (zh) * 2012-02-08 2015-08-26 江西青峰药业有限公司 Lupane三萜系衍生物及其药学用途
WO2013160810A2 (en) 2012-04-24 2013-10-31 Hetero Research Foundation Novel betulinic acid derivatives as hiv inhibitors
JP2016503030A (ja) 2012-12-14 2016-02-01 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ 医薬組成物
US9637516B2 (en) 2012-12-31 2017-05-02 Hetero Research Foundation Betulinic acid proline derivatives as HIV inhibitors
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
WO2015198263A2 (en) 2014-06-26 2015-12-30 Hetero Research Foundation Novel betulinic proline substituted derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
US10370405B2 (en) 2015-03-16 2019-08-06 Hetero Labs Limited C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
WO2017017630A1 (en) 2015-07-28 2017-02-02 Hetero Research Foundation Novel betulinic substituted amide derivatives as hiv inhibitors
WO2017021922A1 (en) 2015-08-05 2017-02-09 Hetero Research Foundation Novel substituted amides of triterpene derivatives as hiv inhibitors
WO2017064628A1 (en) 2015-10-13 2017-04-20 Hetero Research Foundation C-3 novel triterpenone with c-28 urea derivatives as hiv inhibitors
WO2017115329A1 (en) 2015-12-30 2017-07-06 Hetero Research Foundation C-3 novel triterpenone derivatives as hiv inhibitors
WO2017149518A1 (en) 2016-03-04 2017-09-08 Hetero Labs Limited C-3 novel triterpene with c-17 amine derivatives as hiv inhibitors
WO2018025247A1 (en) 2016-08-05 2018-02-08 Hetero Labs Limited C-3 novel triterpenone with c-28 diamide derivatives as hiv inhibitors
WO2018029602A1 (en) 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-28 heterocycle derivatives as hiv inhibitors
WO2018029604A1 (en) 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors
WO2018029610A1 (en) 2016-08-09 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 n-amide derivatives as hiv inhibitors
US20180097839A1 (en) 2016-10-01 2018-04-05 Neeraj S. Upasani Systems, apparatuses, and methods for platform security
WO2018069857A1 (en) 2016-10-12 2018-04-19 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide heterocycle derivatives as hiv inhibitors

Also Published As

Publication number Publication date
CU20170102A7 (es) 2018-01-10
PE20171433A1 (es) 2017-09-26
US11034718B2 (en) 2021-06-15
US20170008921A1 (en) 2017-01-12
EP3256483A2 (en) 2017-12-20
US20180215780A1 (en) 2018-08-02
WO2016178092A8 (en) 2017-09-21
CU24476B1 (es) 2020-03-04
US20200087342A1 (en) 2020-03-19
BR112017017109A2 (pt) 2018-04-03
KR20170110143A (ko) 2017-10-10
ES2780649T3 (es) 2020-08-26
WO2016178092A3 (en) 2017-01-05
CA2975359A1 (en) 2016-11-10
CO2017008765A2 (es) 2017-11-10
MA40886B1 (fr) 2020-03-31
ZA201705253B (en) 2020-01-29
AU2016258274A1 (en) 2017-09-07
MX2017010297A (es) 2018-11-12
CL2017002034A1 (es) 2018-04-27
SG11201706189PA (en) 2017-08-30
CN107428797A (zh) 2017-12-01
WO2016178092A2 (en) 2016-11-10
EA201791807A1 (ru) 2018-01-31
IL253844A0 (en) 2017-09-28
US10533035B2 (en) 2020-01-14
EA033264B1 (ru) 2019-09-30
JP2018505216A (ja) 2018-02-22
AU2016258274B2 (en) 2019-12-05
PH12017550077A1 (en) 2018-02-12
EP3256483B1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
DK3661921T3 (da) Selektive hæmmere af nlrp3-inflammasom
DK3464271T3 (da) Pyrazolderivater som plasma-kallikreininhibitorer
DK3580220T3 (da) Aminotriazolpyridiner som kinasehæmmere
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3324977T3 (da) Benzodiazepinderivater som rsv-inhibitorer
LT3303334T (lt) Tirozinkinazės inhibitoriai
LT3122752T (lt) 4'-pakeistųjų nukleozidų dariniai kaip živ atvirkštinės transkriptazės inhibitoriai
DK3348556T3 (da) Heteroarylamider som hæmmere af proteinaggregering
LT3319959T (lt) Histono deacetilazės hetero-halogeno inhibitoriai
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
EP3313828A4 (en) METALLO-BETA-Lactamase INHIBITORS
DK3204378T6 (da) N-pyridinylacetamidderivater som hæmmere af wnt-signaleringsbanen
IL254779A0 (en) Methods of administering glutaminase inhibitors
DK3182962T3 (da) Compositions and uses of amidine derivatives
DK3310340T3 (da) Formulering med høj koncentration
DK3704118T3 (da) Aminoimidazopyrazin som kinasehæmmere
DK3168219T3 (da) Pyridonderivat med tetrahydropyranylmethylgruppe
DK3389379T3 (da) Mikrobiocide phenylamidinderivater
HUE052642T2 (hu) DOPA dekarboxiláz inhibitor készítmények
DK3544981T3 (da) Benzodiazoliumforbindelser som enac-inhibitorer
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
MA43367A (fr) Inhibiteurs de métallo-bêta-lactamases
LT3371168T (lt) Indolin-2-ono dariniai
DK3227325T3 (da) Sammensætninger med selektive hæmmere af il-6-trans-signalering
DK3265057T3 (da) Topisk formulering